文 献9）Khattri RB, Thome T, Ryan TE. Tissue-specific 1H-NMR metabolomic profiling in mice with adenine-induced chronic kidney disease. Metabolites 2021; 11: 45.10）Vandenbussche C, Van der Hauwaert C, Dewaeles E, Franczak J, Hennino MF, Gnemmi V, et al. Tacrolimus-induced nephrotoxicity in mice is associated with microRNA deregulation. Arch Toxicol 2018; 92: 1539-50.11）Xie D, Guo J, Dang R, Li Y, Si Q, Han W, et al. The effect of tacrolimus-induced toxicity on metabolic profiling in target tissues of mice. BMC Pharmacol Toxicol 2022; 23: 87.12）Oyanagi E, Yano H, Uchida M, Utsumi K, Sasaki J. Protective action of L-carnitine on cardiac mitochondrial function and structure against fatty acid stress. Biochem Biophys Res Commun 2011; 412: 61-7.13）Zambrano S, Blanca AJ, Ruiz-Armenta MV, Miguel-Carrasco JL, Arévalo M, Mate A, et al. L-carnitine attenuates the development of kidney fibrosis in hypertensive rats by upregulating PPAR-γ. Am J Hypertens 2014; 27: 460-70.14）Tanaka M, Nakamura F, Mizokawa S, Matsumura A, Matsumura K, Watanabe Y. Role of acetyl-L-carnitine in the brain: revealed by Bioradiography. Biochem Biophys Res Commun 2003; 306: 1064-9.15）Dubin RF, Rhee EP. Proteomics and metabolomics in kidney disease, including insights into etiology, treatment, and prevention. Clin J Am Soc Nephrol 2020; 15: 404-11.1321）Ekberg H, Tedesco-Silva H, Demirbas A, Vítko Š, Nashan B, Gürkan A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Eng J Med 2007; 357: 2562-75.2）Wojciechowski D, Wiseman A. Long-term immunosuppression management: opportunities and uncertainties. Clin J Am Soc Nephrol 2021; 16: 1264-71.3）Farouk SS, Rein JL. The many faces of calcineurin inhibitor toxicity—What the FK? Adv Chronic Kidney Dis 2020; 27: 56-66.4）Nankivell BJ, Borrows RJ, Fung CLS, O'Connell PJ, Allen RDM, Chapman JR. The natural history of chronic allograft nephropathy. N Eng J Med 2003; 349: 2326-33.5）Bentata Y. Tacrolimus: 20 years of use in adult kidney transplantation. What we should know about its nephrotoxicity. Artif Organs 2020; 44: 140-52.6）Zhou X, Yang G, Davis CA, Doi SQ, Hirszel P, Wingo CS, et al. Hydrogen peroxide mediates FK506-induced cytotoxicity in renal cells. Kidney Int 2004; 65: 139-47.7）Randhawa PS, Shapiro R, Jordan ML, Starzl TE, Demetris AJ. The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine. Am J Surg Pathol 1993; 17: 60-8.8）Wang YN, Ma SX, Chen YY, Chen L, Liu BL, Liu QQ, et al. Chronic kidney disease: Biomarker diagnosis to therapeutic targets. Clin Chim Acta 2019; 499: 54-63.
元のページ ../index.html#146